Navigation Links
Genalyte Announces CE Mark For Maverick(TM) Detection System And Signs On First European Distributors

SAN DIEGO, March 26, 2013 /PRNewswire/ -- Genalyte, Inc. today announced its Maverick™ Detection System that simultaneously analyzes multiple antibodies and other proteins from a single small sample is now CE marked in Europe for research use.  The company also reported its first European distribution agreements for the Maverick Detection System, signing on specialty distributors Mokascience in France, Bucher Biotec in Switzerland and KRD Molecular Technologies in the Czech Republic, Slovakia and Hungary.

Genalyte's Maverick Detection System uses a silicon chip containing arrays of photonic ring sensors that simultaneously analyze multiple antibodies and other proteins from a single small sample. The one-step workflow of the Maverick multiplex system can deliver accurate results in as little as 15 minutes from small volume samples of many types. The Maverick platform has a large dynamic range and excellent sensitivity with outstanding reproducibility.

"The Maverick System and our growing family of multiplex assays have generated a great deal of interest in Europe, so this CE mark designation and the appointment of our first European distributors are especially timely," said Martin Gleeson , PhD, Chief Scientific Officer of Genalyte.  "We plan to launch several new multiplex assays in the coming months and also expect to announce additional distributor agreements as we build a distribution network to reach pharmaceutical, biotechnology and academic researchers around the globe."

The Maverick Detection System and its ENA 4, ENA 6 and ANA 14 Assay Kits are commercially available.  Assay kits for SLE, Sjogren's syndrome and type I diabetes research are available under Genalyte's Technology Access Program.  Additionally, Genalyte offers researchers a Custom Spotting Service that loads proteins supplied by customers, such as antibodies, peptides, biomarkers, cytokines and antigens, onto standard-format Genalyte chips that are ready to be run on the Maverick System.

For more information, visit Maverick assays are currently available for research use only.

About Genalyte
Founded in 2007, Genalyte, Inc. is commercializing the Maverick™ detection platform based on the company's revolutionary Microring Sensor Technology™ a new approach to multiplexing that leverages advances in silicon photonics to reduce or eliminate sample preparation, provide scalable multiplexing for both proteins and nucleic acids from a single small sample, and achieve excellent sensitivity and up to eight logs of dynamic range. 

About Bucher Biotec
Bucher Biotec AG is a privately held Swiss distributor representing some of the most advanced US and European manufacturers of highly innovative life science research instrumentation, associated reagents and consumables. The company's customer base includes the pharmaceutical, biotechnology and agricultural and food-related industries, along with life science research institutions, clinical and environmental labs and university hospitals. The Bucher team focuses on understanding customers' needs in order to propose optimal solutions to demanding research tasks and to help accelerate scientific exploration. For more information, visit

About Mokascience
Mokascience's team of experienced and technology/application-driven people provide innovative and reliable products with demonstrated added-value to Life Science researchers in the pharmaceutical and biotechnology industries and at academic labs and biobanks in France. The company works closely with its suppliers to provide the best support to customers, and the quality of its pre- and post-sales service is a top priority. For more information, visit

About KRD Molecular Technologies
KRD is a private distribution company focused on the provision of high quality products and services to life science organizations in the Czech Republic, Slovakia and Hungary. Its clients include major scientific institutions, universities, hospitals and pharmaceutical and biomedical companies. Its portfolio includes laboratory equipment, specialized workstations and instruments, molecular biology reagents, laboratory consumables and software. KRD is committed to service quality and has been awarded an ISO 9001:2011 certificate. For more information visit Contacts: Genalyte, Inc.

Media: Martin Gleeson, PhD

BLL Partners, LLC Chief Scientific Officer

Barbara Lindheim +1 858 750-4470

+1 212 584-2276

SOURCE Genalyte, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Genalyte Awarded $500,000 SBIR Grant To Develop Multiplexed Assays For Early Detection And Monitoring Of Type 1 Diabetes
2. Omeros Announces Successful Completion of PDE10 Phase 1 Multiple Ascending Dose Trial
3. ECRI Institute Announces 2013 Health Devices Achievement Award -- Call for Entries
4. ULURU Inc. Announces Conference Call to Discuss Financial Results for the Fourth Quarter and Year Ended December 31, 2012 and to Provide a Business Update
5. Research and Markets Announces The Release of Neuromodulation Market - Forecasts to 2017
6. SARcode Bioscience Announces Acquisition by Shire US Holdings Inc.
7. Creative Edge Nutrition, Inc. Announces the Entrance into the Medical Marijuana Sector
8. arGEN-X Announces Preclinical Development of ARGX-112 for Dermatology
9. United Therapeutics Announces Receipt Of Second Complete Response Letter For Oral Treprostinil NDA
10. Sihuan Pharmaceutical Announces 2012 Annual Results
11. 3SBio Inc. Announces Extraordinary General Meeting of Shareholders
Post Your Comments:
(Date:11/26/2015)... 26, 2015 ... of the  "2016 Future Horizons and ... Drug Monitoring (TDM) Market: Supplier Shares, ... Opportunities"  report to their offering.  ... the addition of the  "2016 Future ...
(Date:11/26/2015)... , Nov. 26, 2015 Research ... addition of the "2016 Future Horizons and ... (TDM) Market: Supplier Shares, Country Segment Forecasts, Competitive ... --> --> ... analysis of the Italian therapeutic drug monitoring market, ...
(Date:11/25/2015)... 25, 2015 ... the "Global Brain Monitoring Devices Market ... --> ) has announced the ... Devices Market 2015-2019" report to their ... ( ) has announced the addition ...
Breaking Medicine Technology:
(Date:11/27/2015)... ... 27, 2015 , ... A team of Swiss doctors has released a report ... has just posted the findings on the website. Click here to read the ... 136 mesothelioma patients who were treated with chemotherapy followed by EPP surgery. Among the ...
(Date:11/27/2015)... ... 2015 , ... Lizzie’s Lice Pickers just announced a special promotion that will ... their purchase of lice treatment product. In addition, customers will receive a complimentary head ... “Finding lice is a sure way to ruin the holidays, so we encourage all ...
(Date:11/27/2015)... ... , ... MPWH, the No.1 Herpes-only dating community in the world, revealed that over 50% of ... than 3.7 billion people under the age of 50 – or 67% of the population ... global estimates of HSV-1 infection . , "The data shocks us highly!" said Michelle ...
(Date:11/27/2015)... ... ... A simply groundbreaking television series, "Voices in America", which is hosted by Hollywood legend, ... that are presently affecting Americans. Dedicated to providing the world with a wide variety ... consumers focus on, one episode at a time. , In the latest installment ...
(Date:11/27/2015)... Angeles, CA (PRWEB) , ... November 27, 2015 , ... ... Commission on Accreditation of Allied Health Education Programs (CAAHEP) awarded accreditation to its Diagnostic ... list of CAAHEP accredited colleges, as only one of twelve colleges and universities in ...
Breaking Medicine News(10 mins):